PET imaging in multiple sclerosis
- PMID: 24809810
- DOI: 10.1007/s11481-014-9544-2
PET imaging in multiple sclerosis
Abstract
Positron emission tomography (PET) is a non-invasive technique for quantitative imaging of biochemical and physiological processes in animals and humans. PET uses probes labeled with a radioactive isotope, called PET tracers, which can bind to or be converted by a specific biological target and thus can be applied to detect and monitor different aspects of diseases. The number of applications of PET imaging in multiple sclerosis is still limited. Clinical studies using PET are basically focused on monitoring changes in glucose metabolism and the presence of activated microglia/macrophages in sclerotic lesions. In preclinical studies, PET imaging of targets for other processes, like demyelination and remyelination, has been investigated and may soon be translated to clinical applications. Moreover, more PET tracers that could be relevant for MS are available now, but have not been studied in this context yet. In this review, we summarize the PET imaging studies performed in multiple sclerosis up to now. In addition, we will identify potential applications of PET imaging of processes or targets that are of interest to MS research, but have yet remained largely unexplored.
Similar articles
-
PET imaging of glucose metabolism, neuroinflammation and demyelination in the lysolecithin rat model for multiple sclerosis.Mult Scler. 2014 Oct;20(11):1443-52. doi: 10.1177/1352458514526941. Epub 2014 Mar 12. Mult Scler. 2014. PMID: 24622349
-
Predicting PET-derived myelin content from multisequence MRI for individual longitudinal analysis in multiple sclerosis.Neuroimage. 2020 Dec;223:117308. doi: 10.1016/j.neuroimage.2020.117308. Epub 2020 Sep 2. Neuroimage. 2020. PMID: 32889117
-
PET imaging of demyelination and remyelination in the cuprizone mouse model for multiple sclerosis: a comparison between [11C]CIC and [11C]MeDAS.Neuroimage. 2014 Feb 15;87:395-402. doi: 10.1016/j.neuroimage.2013.10.057. Epub 2013 Nov 2. Neuroimage. 2014. PMID: 24188813
-
PET in multiple sclerosis.Clin Nucl Med. 2015 Jan;40(1):e46-52. doi: 10.1097/RLU.0000000000000359. Clin Nucl Med. 2015. PMID: 24561681 Review.
-
Positron emission tomography imaging in evaluation of MS pathology in vivo.Mult Scler. 2018 Oct;24(11):1399-1412. doi: 10.1177/1352458518791680. Epub 2018 Aug 9. Mult Scler. 2018. PMID: 30091657 Review.
Cited by
-
Potential of [11C](R)-PK11195 PET Imaging for Evaluating Tumor Inflammation: A Murine Mammary Tumor Model.Pharmaceutics. 2022 Dec 4;14(12):2715. doi: 10.3390/pharmaceutics14122715. Pharmaceutics. 2022. PMID: 36559209 Free PMC article.
-
Cognitive impairment and World Trade Centre-related exposures.Nat Rev Neurol. 2022 Feb;18(2):103-116. doi: 10.1038/s41582-021-00576-8. Epub 2021 Nov 18. Nat Rev Neurol. 2022. PMID: 34795448 Free PMC article. Review.
-
Detecting neurodegenerative pathology in multiple sclerosis before irreversible brain tissue loss sets in.Transl Neurodegener. 2019 Dec 9;8:37. doi: 10.1186/s40035-019-0178-4. eCollection 2019. Transl Neurodegener. 2019. PMID: 31827784 Free PMC article. Review.
-
Molecular imaging of multiple sclerosis: from the clinical demand to novel radiotracers.EJNMMI Radiopharm Chem. 2019 Apr 8;4(1):6. doi: 10.1186/s41181-019-0058-3. EJNMMI Radiopharm Chem. 2019. PMID: 31659498 Free PMC article. Review.
-
Detecting Demyelination by PET: The Lesion as Imaging Target.Mol Imaging. 2018 Jan-Dec;17:1536012118785471. doi: 10.1177/1536012118785471. Mol Imaging. 2018. PMID: 30039728 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical